Overview
Sweden assistive communication firm's Q4 revenue grew 16% but missed analyst expectations
Basic EPS for Q4 increased to SEK 0.72 from SEK 0.51
Company entered agreement to acquire Italian partner SR Labs Healthcare
Outlook
Dynavox plans ERP rollouts outside North America in early 2026 at lower costs
Dynavox aims to close SR Labs Healthcare acquisition in first half of 2026
Dynavox's outlook remains unchanged; proposes dividend of 0.5 SEK per share
Result Drivers
PRODUCT DEMAND - Sustained demand for assistive communication products, particularly for younger users with autism and eye-gaze solutions, supported revenue growth
CURRENCY AND COST IMPACT - Currency effects and non-recurring costs negatively impacted profitability, but operating margin remained strong
INVESTMENTS FOR GROWTH - Major investments in organizational consolidation and ERP system implementation to support future scalability
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Miss
SEK 677 mln
SEK 705.70 mln (5 Analysts)
Q4 Gross Margin
69.00%
Q4 Basic EPS
SEK 0.72
Q4 Operating Margin
15.20%
Q4 Operating Profit
SEK 103 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the integrated hardware & software peer group is "buy"
Wall Street's median 12-month price target for Dynavox Group AB is SEK132.50, about 53.7% above its February 4 closing price of SEK86.20
The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 30 three months ago
Press Release: ID:nWkrmdNLG
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)